> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-214/
- Published: 2019-03-10T12:00:00.000Z
- Updated: 2026-09-15T01:11:12.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5143575

[**Comments Sought on Info Collection for CDRH Appeals**](https://www.fdaweb.com/comments-sought-on-info-collection-for-cdrh-appeals/)  
*Federal Register* notice: FDA seeks comments on an information collection extension for “Center for Devices and Radiological Health Appeals Processes.” 03/08/2019

[**New Info Collection on Bio Product Name Suffix**](https://www.fdaweb.com/new-info-collection-on-bio-product-name-suffix/)  
*Federal Register* notice: FDA seeks comments on a new information collection for “Proposed Suffix for the Proper Name of a Biological Product.” 03/08/2019

[**Draft Guide on Biologic Product Nonproprietary Naming**](https://www.fdaweb.com/draft-guide-on-biologic-product-nonproprietary-naming/)  
*Federal Register* notice: FDA makes available a draft guidance entitled “Nonproprietary Naming of Biological Products: Update.” 03/08/2019

[**Panel to Discuss Testosterone Replacement Therapy Development**](https://www.fdaweb.com/panel-to-discuss-testosterone-replacement-therapy-development/)  
*Federal Register* notice: FDA announces a 4/8 Pediatric Advisory Committee meeting to discuss drug development for testosterone replacement therapy in male adolescents. 3/07/2019

[**510(k) Exemption Proposed for Flow Cytometer Instruments**](https://www.fdaweb.com/510-k-exemption-proposed-for-flow-cytometer-instruments/)  
*Federal Register* notice: FDA seeks comments on its announced intention to exempt certain flow cytometer instruments from premarket notification requirements, subject to conditions and limitations. 03/06/2019

[**Software Apps for Contraception Placed into Class 2**](https://www.fdaweb.com/software-apps-for-contraception-placed-into-class-2/)  
*Federal Register* notice: FDA classifies software applications for contraception into Class 2 (special controls). 03/06/2019

[**Comments Sought on Info Collection for IVD Study Guide**](https://www.fdaweb.com/comments-sought-on-info-collection-for-ivd-study-guide/)  
*Federal Register* notice: FDA seeks comments on an information collection extension for its “Guidance on Informed Consent for In Vitro Diagnostic Device Studies Using Leftover Human Specimens That Are Not Individually Identifiable.”03/05/2019